Pyridostigmine as Immunomodulator in People Living With HIV

Stopped Due to COVID-19, effective 3/19/2020 recruitment is halted until further notice

Conditions

• HIV-1-infection
• CD4+ T Lymphocytopenia
• Immune Deficiency
• Immuno-senescence

Interventions

• DRUG: Pyridostigmine Bromide
• DRUG: Placebo

Sponsor

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran